Location History:
- Atlanta, GA (US) (1995)
- Kennesaw, GA (US) (2009 - 2012)
Company Filing History:
Years Active: 1995-2012
Title: Innovator Spotlight: Michael W Hager - Pioneering Breakthroughs in Viral Infection Treatment
Introduction:
Michael W Hager, a distinguished inventor based in Atlanta, GA (US), is making waves in the field of medical innovations with his groundbreaking research in viral infection treatment. Hager's relentless pursuit of excellence has led to the development of several patents aimed at combating viral infections and abnormal cellular proliferation.
Latest Patents:
Hager's recent patents include the innovative 2' and 3'-substituted cyclobutyl nucleoside analogs. These compounds have shown promising results in the treatment of infections caused by Retroviridae (such as HIV), Hepadnaviridae (including HBV), or Flaviviridae (such as BVDV and HCV). Moreover, these nucleosides offer potential therapeutic solutions for conditions related to abnormal cellular proliferation, marking a significant advancement in the medical field.
Career Highlights:
Hager is an invaluable asset to Emory University, where his groundbreaking research is supported and nurtured. His dedication to advancing medical science has led to the issuance of four patents, each representing a significant milestone in the fight against viral infections and abnormal cellular growth. Hager's contributions have not only earned him recognition but have also positioned him as a key figure in the field of medical research.
Collaborations:
Throughout his career, Hager has collaborated closely with esteemed colleagues such as Dennis C Liotta and Shuli Mao. Together, they have fostered a culture of innovation and excellence, driving forward cutting-edge research initiatives that have the potential to revolutionize the treatment of viral infections and abnormal cellular proliferation.
Conclusion:
In conclusion, Michael W Hager's pioneering work in the development of 2' and 3'-substituted cyclobutyl nucleoside analogs underscores his commitment to advancing medical science. His dedication, coupled with his collaborative spirit and visionary approach, positions him as a trailblazer in the field of viral infection treatment. As Hager continues to push the boundaries of innovation, his impact on the medical community is sure to be felt for years to come.